AMPK Activity: A Primary Target for Diabetes Prevention with Therapeutic Phytochemicals

被引:23
|
作者
Chung, Min-Yu [1 ]
Choi, Hyo-Kyoung [1 ]
Hwang, Jin-Taek [1 ,2 ]
机构
[1] Korea Food Res Inst, Personalized Diet Res Grp, Jeonju 55365, South Korea
[2] Univ Sci & Technol, Dept Food Biotechnol, Daejeon 34113, South Korea
关键词
diabetes; AMP-activated protein kinase; medicinal plants; ingredient; ACTIVATED PROTEIN-KINASE; STIMULATES GLUCOSE-UPTAKE; SKELETAL-MUSCLE CELLS; MITOCHONDRIAL BIOGENESIS; NATURAL-PRODUCT; BLOOD-GLUCOSE; PGC-1; ALPHA; BETA-CELLS; INSULIN; MECHANISMS;
D O I
10.3390/nu13114050
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Diabetes is a metabolic syndrome characterized by inadequate blood glucose control and is associated with reduced quality of life and various complications, significantly shortening life expectancy. Natural phytochemicals found in plants have been traditionally used as medicines for the prevention of chronic diseases including diabetes in East Asia since ancient times. Many of these phytochemicals have been characterized as having few side effects, and scientific research into the mechanisms of action responsible has accumulated mounting evidence for their efficacy. These compounds, which may help to prevent metabolic syndrome disorders including diabetes, act through relevant intracellular signaling pathways. In this review, we examine the anti-diabetic efficacy of several compounds and extracts derived from medicinal plants, with a focus on AMP-activated protein kinase (AMPK) activity.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] The vascular endothelium in diabetes—a therapeutic target?
    Kieren J. Mather
    Reviews in Endocrine and Metabolic Disorders, 2013, 14 : 87 - 99
  • [42] Stem cells as a therapeutic target for diabetes
    Mishra, Paras Kumar
    Singh, Shree Ram
    Joshua, Irving G.
    Tyagi, Suresh C.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2010, 15 : 461 - 477
  • [43] An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus
    Klein, Janet D.
    Khanna, Ish
    Pillarisetti, Ram
    Hagan, Rachael A.
    LaRocque, Lauren M.
    Rodriguez, Eva L.
    Sands, Jeff M.
    JCI INSIGHT, 2021, 6 (08)
  • [44] Aspirin in primary prevention: who is the target?
    Gatto, Laura
    Romagnoli, Enrico
    Prati, Francesco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0B) : B54 - B54
  • [45] AMPK: a therapeutic target of heart failure-not only metabolism regulation
    Li, Xuan
    Liu, Jia
    Lu, Qingguo
    Ren, Di
    Sun, Xiaodong
    Rousselle, Thomas
    Tan, Yi
    Li, Ji
    BIOSCIENCE REPORTS, 2019, 39
  • [46] AMPK Signaling Pathway as a Potential Therapeutic Target for Parkinson's Disease
    Athari, Seyed Zanyar
    Farajdokht, Fereshteh
    Keyhanmanesh, Rana
    Mohaddes, Gisou
    ADVANCED PHARMACEUTICAL BULLETIN, 2024, 14 (01) : 120 - 131
  • [47] AMPK as a Therapeutic Target: Advancing Epilepsy Management Through Metabolic Modulation
    Dhureja, Maanvi
    Munshi, Anjana
    Kumar, Puneet
    MOLECULAR NEUROBIOLOGY, 2025,
  • [48] Prevention of immunoglobulin E production as a therapeutic target
    Woisetschläger, M
    Stütz, AM
    Ettmayer, P
    DRUG NEWS & PERSPECTIVES, 2002, 15 (02) : 78 - 84
  • [49] Prevention of Ankylosis: A Specific Therapeutic Target in Spondyloarthritis
    Lories, Rik J. U.
    de Vlam, Kurt
    CURRENT RHEUMATOLOGY REVIEWS, 2007, 3 (04) : 317 - 321
  • [50] Myeloperoxidase: A promising therapeutic target in prevention of atherosclerosis
    Long, Lili
    Song, Yanmin
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 256 : 15 - 15